Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma
AbbVie (prior sponsor, Abbott)
· 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
multiple-myeloma
hematologic cancer, multiple myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
#1033723
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
#1033716
The Effect of Nicorandil on Rheumatoid Arthritis Patients
#1033725
Acupuncture for Heel Pain Syndrome
#1033717
A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
#1033719
Record
· ID 993863
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.